Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study details, indicating that access to the record is blocked. This prevents viewing the trial information for this entry.
    Difference
    18%
    Check dated 2026-09-23T20:50:43.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows an updated release revision v3.7.0, replacing the prior v3.6.6. This signals a backend or UI update to the ClinicalTrials.gov entry without any changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T21:58:04.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a new version of the page rendering used for the study record.
    Difference
    0.1%
    Check dated 2026-09-02T19:32:48.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-08-12T09:18:27.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a newer version of the study page.
    Difference
    0.1%
    Check dated 2026-07-21T23:18:51.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.3, indicating a recent maintenance/update to the page. This update is a backend/page-history change rather than a visible change to study details or participation information.
    Difference
    0.1%
    Check dated 2026-06-30T10:53:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.